Mark Anderson

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection

Michel Bazinet, Victor Pântea, Valentin Cebotarescu et al. · Hepatology Communications · 2020 · 81 citations · Full text

SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine

Mark Anderson, Michael Stec, Ayesan Rewane et al. · JAMA Network Open · 2021 · 53 citations · Full text

Vaccination, Vaccinology, Bnt162b2 Vaccine +10

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen

Mary C. Kuhns, Vera Holzmayer, Mark Anderson et al. · Viruses · 2021 · 31 citations · Full text

Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy

Mark Anderson, Jeffery Gersch, Ka‐Cheung Luk et al. · Clinical Infectious Diseases · 2020 · 22 citations

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy

Michel Bazinet, Mark Anderson, Victor Pântea et al. · Hepatology Communications · 2021 · 20 citations · Full text